金妇康品牌怎么样 申请店铺

更新时间:2023-03-31
金妇康是哪个国家的品牌?「金妇康」是 中华茂祥集团有限公司 旗下著名品牌。该品牌发源于吉林省通化市,由创始人王瀚基在1996-02-08期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
金妇康怎么样

创建于1984年,乌鸡白凤丸行业知名品牌,以医药为主,兼营房产/葡萄酒等生产的多元化集团企业


中华茂祥集团有限公司创业于1984年,经过二十年的不懈努力,公司已发展为医药为主,同时兼营房产、葡萄酒等生产,总资产12.5亿元的多元化的集团企业。占地面积65万平方米,总建筑面积5.5万平方米,员工近5000人,市场网络遍布全国。集团下设通化茂祥制药有限公司、通化茂祥药业股份有限公司、茂祥集团(长春)制药有限公司、茂祥集团(吉林)制药有限公司、吉林省祥和房地产开发有限公司、通化茂祥葡萄酒股份有限公司、通化市新华彩印厂等多家子公司。

多年来,中华茂祥集团有限公司本着开拓进取、求实创新的宗旨,为对社会、对人民高度负责的态度,自主经营、自我发展,注重产品开发,信守“营造健康、维护健康和为生命创造奇迹”的理念,坚持科技创新,科技投入达到年销售收入的15%以上,加速成果转化和新药品的产业化,立足医药,不断增强医药产业核心竞争力,使茂祥集团的经济发展呈现出良性循环的可喜势头。集团现有按国家GMP标准设计的注射用抗生素粉针剂和固体制剂、液体制剂等多条制药生产线,可生产化学合成原料药和胶囊剂(含缓释剂、控释制剂)、片剂(含缓释剂、控释剂)、颗粒剂、粉针剂、水针剂、软胶囊、滴丸、口服液、糖浆剂、软膏、栓剂、蜜丸13种剂型289个品种。公司生产系列中西药产品泰克、金妇康、安神胶囊、先泰、普舒等以良好的疗效赢得广大患者的认可,成为国内出色品牌。


Founded in 1984, Zhonghua Maoxiang Group Co., Ltd., a well-known brand in Wuji Baifeng pill industry, was founded in 1984. After 20 years of unremitting efforts, the company has developed into a diversified group enterprise with a total assets of 1.25 billion yuan, mainly engaged in the production of real estate and wine. Covering an area of 650000 square meters, with a total construction area of 55000 square meters and nearly 5000 employees, the market network covers the whole country. The group consists of Tonghua Maoxiang Pharmaceutical Co., Ltd., Tonghua Maoxiang Pharmaceutical Co., Ltd., Maoxiang group (Changchun) Pharmaceutical Co., Ltd., Maoxiang group (Jilin) Pharmaceutical Co., Ltd., Jilin Xianghe Real Estate Development Co., Ltd., Tonghua Maoxiang Wine Co., Ltd., Tonghua Xinhua color printing factory and other subsidiaries. Over the years, China Maoxiang Group Co., Ltd. adheres to the tenet of pioneering, realistic and innovative, pays attention to product development, adheres to the philosophy of "creating health, maintaining health and creating miracles for life", adheres to scientific and technological innovation, achieves more than 15% of annual sales revenue in scientific and technological investment, and accelerates the transformation of achievements And the industrialization of new drugs, based on medicine, constantly enhance the core competitiveness of the pharmaceutical industry, so that the economic development of Maoxiang group presents a positive cycle of gratifying momentum. At present, the group has many pharmaceutical production lines designed according to the national GMP standards, such as antibiotic powder for injection, solid preparation and liquid preparation, which can produce chemical synthetic APIs and capsules (including sustained-release and controlled-release preparations), tablets (including sustained-release and controlled-release agents), granules, powder injection, water injection, soft capsule, drop pill, oral liquid, syrup, ointment, suppository and honeypill 13 289 kinds of dosage forms. The company produces a series of Chinese and Western medicine products, such as Taike, Jinfukang, Anshen capsule, Xiantai, proshu, etc., which win the recognition of the majority of patients with good curative effect and become an excellent brand in China.

本文链接: https://brand.waitui.com/7da436a8d.html 联系电话:04353197011

7×24h 快讯

RoboSense与上汽集团进入规模化量产合作新阶段

36氪获悉,RoboSense速腾聚创正式公布与上汽集团旗下汽车品牌飞凡汽车的定点合作。日前,双方合作的车型之一飞凡F7正式上市交付。这标志着,RoboSense速腾聚创与上汽集团的量产车型定点合作全面进入了规模化量产的新阶段。

2小时前

热门中概股美股盘前多数上涨,京东涨超5%

36氪获悉,热门中概股美股盘前多数上涨,截至发稿,京东涨超5%,拟分拆京东产发、京东工业于香港联交所主板独立上市;微博涨超3%,拼多多、蔚来、小鹏汽车、爱奇艺涨超1%,B站涨0.49%,理想汽车涨0.24%,百度跌超2%。

2小时前

贵州茅台:2022年净利润627.16亿元,同比增长19.55%

36氪获悉,贵州茅台发布年报,2022年营业收入1240.99亿元,同比增长16.87%;净利润627.16亿元,同比增长19.55%;基本每股收益49.93元。拟10派259.11元。

2小时前

天齐锂业:2022年净利润241.25亿元,同比增长1060.47%

36氪获悉,天齐锂业发布年报,2022年营业收入404.48亿元,同比增长427.82%;净利润241.24亿元,同比增长1060.47%,拟10派30元。

2小时前

亚朵集团上市后首份成绩单:2022年调整后净利润同比增85.6%至2.59亿元

亚朵集团发布2022年第四季度及全年业绩报告。2022年,亚朵集团实现营收22.63亿元,同比增长5.4%;调整后净利润(非公认会计准则)为2.59亿元,同比增长85.6%。截至2022年12月31日,亚朵集团现金及现金等价物为15.89亿元。报告期内,亚朵新开店191家,仅4家关店,在营酒店数量达932家,房间数达10.8万间,均较上年增长25%;场景零售业务增长迅猛,GMV同比增长42%至3.24亿元。

2小时前

本页详细列出关于金妇康的品牌信息,含品牌所属公司介绍,金妇康所处行业的品牌地位及优势。
咨询